Vir Biotechnology Inc. (VIR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Vir Biotechnology Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$11.93
+3.11% today
Market cap
$2.0B
Overall quality
—
Kronos AI 30-day
−17.2%
0 of 8 simulated paths end higher
Vir Biotechnology Inc. (VIR) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $2.0B. It trades at $11.93, up 3.11% today. 8 analysts' average target of $21.29 implies +78.5% from today's price. Kronos AI's 30-day forecast is −17.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.29 |
| Low – high | $15.00 – $30.00 |
| Analysts | 8 |
| Upside to average | +78.5% |
Kronos AI 30-day forecast
| Expected close | $9.58 (−17.2%) |
| Likely range | −23.2% … −9.4% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.